Skip to main content
Erschienen in: Head and Neck Pathology 1/2020

11.04.2019 | Original Paper

Patterns of LC3A Autophagy Protein Expression in Keratoacanthomas

verfasst von: Efthimios Sivridis, Ioannis M. Koukourakis, Stella Arelaki, Kostantina Balaska, Antonios Karpouzis, Alexandra Giatromanolaki

Erschienen in: Head and Neck Pathology | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Abstract

To investigate the expression patterns of autophagy marker light chain protein 3 (LC3A) in keratoacanthoma (KA). KAs are generally regarded as benign but malignant behavior, including rare metastases, may occur. 85 KAs were assessed for the LC3A autophagic protein by immunohistochemistry. Diffuse cytoplasmic staining and a “stone-like structure” (SLS) characterized positive expression. Thirty-four out of 85 KAs (40%) had diffuse cytoplasmic LC3A immunostaining (percentage of positive cells ranging from 5 to 60%). In contrast, only 4 of the 85 KAs (4.7%) expressed SLSs. Only one SLS was detected per histologic section of each tumor. The p53 oncoprotein was encountered in all cases with expression ranging from 1 to 90% of cells (median 30%). The Ki-67 index was expressed in 63 cases (74% of cases; range 1–50% of cells; median value 5%). Neither of these two parameters nor diffuse cytoplasmic LC3A staining was significantly correlated with SLS expression or lack thereof. Expression of SLSs, a hallmark of malignancy, was found in 4.7% of KAs. Further study is necessary to determine whether this fraction represents the exceptional cases that harbor latent malignant potential.
Literatur
1.
Zurück zum Zitat Savage JA, Maize JC, Sr. Keratoacanthoma clinical behavior: a systematic review. Am J Dermatopathol. 2014;36:422–9.PubMed Savage JA, Maize JC, Sr. Keratoacanthoma clinical behavior: a systematic review. Am J Dermatopathol. 2014;36:422–9.PubMed
2.
Zurück zum Zitat Oellers P, Karp CL, Shah RR, et al. Conjunctival keratoacanthoma. Br J Ophthalmol. 2014;98:275–6.PubMed Oellers P, Karp CL, Shah RR, et al. Conjunctival keratoacanthoma. Br J Ophthalmol. 2014;98:275–6.PubMed
3.
Zurück zum Zitat Ko CJ. Keratoacanthoma: facts and controversies. Clin Dermatol. 2010;28:254–61.PubMed Ko CJ. Keratoacanthoma: facts and controversies. Clin Dermatol. 2010;28:254–61.PubMed
4.
Zurück zum Zitat Piscioli F, Boi S, Zumiani G, et al. A gigantic, metastasizing keratoacanthoma. Report of a case and discussion on classification. Am J Dermatopathol. 1984;6:123–9.PubMed Piscioli F, Boi S, Zumiani G, et al. A gigantic, metastasizing keratoacanthoma. Report of a case and discussion on classification. Am J Dermatopathol. 1984;6:123–9.PubMed
5.
Zurück zum Zitat Hodak E, Jones RE, Ackerman AB. Solitary keratoacanthoma is a squamous-cell carcinoma: three examples with metastases. Am J Dermatopathol. 1993;15:332–42.PubMed Hodak E, Jones RE, Ackerman AB. Solitary keratoacanthoma is a squamous-cell carcinoma: three examples with metastases. Am J Dermatopathol. 1993;15:332–42.PubMed
6.
Zurück zum Zitat Mandrell JC, Santa Cruz D. Keratoacanthoma: hyperplasia, benign neoplasm, or a type of squamous cell carcinoma? Semin Diagn Pathol. 2009;26:150–63.PubMed Mandrell JC, Santa Cruz D. Keratoacanthoma: hyperplasia, benign neoplasm, or a type of squamous cell carcinoma? Semin Diagn Pathol. 2009;26:150–63.PubMed
7.
Zurück zum Zitat Weedon D. Weedon’s skin pathology. Keratoacanthoma centrifugum marginatum. Edinburg: Churchill Livingstone Elsevier; 2010. p. 702–8. Weedon D. Weedon’s skin pathology. Keratoacanthoma centrifugum marginatum. Edinburg: Churchill Livingstone Elsevier; 2010. p. 702–8.
8.
Zurück zum Zitat Godbolt AM, Sullivan JJ, Weedon D. Keratoacanthoma with perineural invasion: a report of 40 cases. Australas J Dermatol. 2001;42:168–71.PubMed Godbolt AM, Sullivan JJ, Weedon D. Keratoacanthoma with perineural invasion: a report of 40 cases. Australas J Dermatol. 2001;42:168–71.PubMed
9.
Zurück zum Zitat Weedon D, Malo J, Brooks D, et al. Keratoacanthoma: is it really a variant of squamous cell carcinoma? ANZ J Surg. 2010;80:129–30.PubMed Weedon D, Malo J, Brooks D, et al. Keratoacanthoma: is it really a variant of squamous cell carcinoma? ANZ J Surg. 2010;80:129–30.PubMed
10.
Zurück zum Zitat Ra SH, Su A, Li X, et al. Keratoacanthoma and squamous cell carcinoma are distinct from a molecular perspective. Mod Pathol. 2015;28:799–806.PubMed Ra SH, Su A, Li X, et al. Keratoacanthoma and squamous cell carcinoma are distinct from a molecular perspective. Mod Pathol. 2015;28:799–806.PubMed
11.
Zurück zum Zitat Gleich T, Chiticariu E, Huber M, et al. Keratoacanthoma: a distinct entity? Exp Dermatol. 2016;25:85–91.PubMed Gleich T, Chiticariu E, Huber M, et al. Keratoacanthoma: a distinct entity? Exp Dermatol. 2016;25:85–91.PubMed
12.
Zurück zum Zitat Ogita A, Ansai SI, Misago N, et al. Histopathological diagnosis of epithelial crateriform tumors: Keratoacanthoma and other epithelial crateriform tumors. J Dermatol. 2016;43:1321–31.PubMed Ogita A, Ansai SI, Misago N, et al. Histopathological diagnosis of epithelial crateriform tumors: Keratoacanthoma and other epithelial crateriform tumors. J Dermatol. 2016;43:1321–31.PubMed
13.
Zurück zum Zitat Manstein CH, Frauenhoffer CJ, Besden JE. Keratoacanthoma: is it a real entity? Ann Plast Surg. 1998;40:469–72.PubMed Manstein CH, Frauenhoffer CJ, Besden JE. Keratoacanthoma: is it a real entity? Ann Plast Surg. 1998;40:469–72.PubMed
14.
Zurück zum Zitat Sarma D. Keratoacanthoma should be reported as “well differentiated squamous cell carcinoma, Keratoacanthoma Type”: a dermatopathologist’s view. Internet J Dematol. 2006;5:1. Sarma D. Keratoacanthoma should be reported as “well differentiated squamous cell carcinoma, Keratoacanthoma Type”: a dermatopathologist’s view. Internet J Dematol. 2006;5:1.
15.
Zurück zum Zitat Goldenberg G, Patel S, Patel MJ, et al. Eruptive squamous cell carcinomas, keratoacanthoma type, arising in a multicolor tattoo. J Cutan Pathol. 2008;35:62–4.PubMed Goldenberg G, Patel S, Patel MJ, et al. Eruptive squamous cell carcinomas, keratoacanthoma type, arising in a multicolor tattoo. J Cutan Pathol. 2008;35:62–4.PubMed
16.
Zurück zum Zitat Sivridis E, Koukourakis MI, Zois CE, Ledaki I, Ferguson DJ, Harris AL, Gatter KC, Giatromanolaki A. LC3A-positive light microscopy detected patterns of autophagy and prognosis in operable breast carcinomas. Am J Pathol. 2010;176:2477–89.PubMedPubMedCentral Sivridis E, Koukourakis MI, Zois CE, Ledaki I, Ferguson DJ, Harris AL, Gatter KC, Giatromanolaki A. LC3A-positive light microscopy detected patterns of autophagy and prognosis in operable breast carcinomas. Am J Pathol. 2010;176:2477–89.PubMedPubMedCentral
17.
Zurück zum Zitat Giatromanolaki A, Sivridis E, Mendrinos S, et al. Autophagy proteins in prostate cancer: relation with anaerobic metabolism and Gleason score. Urol Oncol. 2014;32:39.e11-8.PubMed Giatromanolaki A, Sivridis E, Mendrinos S, et al. Autophagy proteins in prostate cancer: relation with anaerobic metabolism and Gleason score. Urol Oncol. 2014;32:39.e11-8.PubMed
18.
Zurück zum Zitat Giatromanolaki A, Koukourakis MI, Harris AL, et al. Prognostic relevance of light chain 3 (LC3A) autophagy patterns in colorectal adenocarcinomas. J Clin Pathol. 2010;63:867–72.PubMed Giatromanolaki A, Koukourakis MI, Harris AL, et al. Prognostic relevance of light chain 3 (LC3A) autophagy patterns in colorectal adenocarcinomas. J Clin Pathol. 2010;63:867–72.PubMed
19.
Zurück zum Zitat Sivridis E, Giatromanolaki A, Karpathiou G, et al. LC3A-positive “stone-like” structures in cutaneous squamous cell carcinomas. Am J Dermatopathol. 2011;33:285–90.PubMed Sivridis E, Giatromanolaki A, Karpathiou G, et al. LC3A-positive “stone-like” structures in cutaneous squamous cell carcinomas. Am J Dermatopathol. 2011;33:285–90.PubMed
20.
Zurück zum Zitat Karpathiou G, Sivridis E, Koukourakis MI, et al. Light-chain 3A autophagic activity and prognostic significance in non-small cell lung carcinomas. Chest. 2011;140:127–34.PubMed Karpathiou G, Sivridis E, Koukourakis MI, et al. Light-chain 3A autophagic activity and prognostic significance in non-small cell lung carcinomas. Chest. 2011;140:127–34.PubMed
21.
Zurück zum Zitat Sivridis E, Koukourakis MI, Mendrinos SE, et al. Patterns of autophagy in urothelial cell carcinomas—the significance of “stone-like” structures (SLS) in transurethral resection biopsies. Urol Oncol. 2013;31:1254–60.PubMed Sivridis E, Koukourakis MI, Mendrinos SE, et al. Patterns of autophagy in urothelial cell carcinomas—the significance of “stone-like” structures (SLS) in transurethral resection biopsies. Urol Oncol. 2013;31:1254–60.PubMed
22.
Zurück zum Zitat Giatromanolaki A, Sivridis E, Mitrakas A, et al. Autophagy and lysosomal related protein expression patterns in human glioblastoma. Cancer Biol Ther. 2014;15:1468–78.PubMedPubMedCentral Giatromanolaki A, Sivridis E, Mitrakas A, et al. Autophagy and lysosomal related protein expression patterns in human glioblastoma. Cancer Biol Ther. 2014;15:1468–78.PubMedPubMedCentral
23.
Zurück zum Zitat Sivridis E, Giatromanolaki A, Liberis V. Autophagy in endometrial carcinomas and prognostic relevance of ‘stone-like’ structures (SLS) What is destined for the atypical endometrial hyperplasia? Autophagy. 2011;7:74–82.PubMed Sivridis E, Giatromanolaki A, Liberis V. Autophagy in endometrial carcinomas and prognostic relevance of ‘stone-like’ structures (SLS) What is destined for the atypical endometrial hyperplasia? Autophagy. 2011;7:74–82.PubMed
24.
Zurück zum Zitat Giatromanolaki A, Koukourakis M, Koutsopoulos, et al. Autophagy and hypoxia in colonic adenomas related to aggressive features. Colorectal Dis. 2013;15:e223-30.PubMed Giatromanolaki A, Koukourakis M, Koutsopoulos, et al. Autophagy and hypoxia in colonic adenomas related to aggressive features. Colorectal Dis. 2013;15:e223-30.PubMed
25.
Zurück zum Zitat Liao W, Sun L, Wang C, Huang H, Liu J, Liao W, Shi M. LC3A-positive “stone-like” structures predict an adverse prognosis of gastric cancer. Anat Rec (Hoboken). 2014;297:653–62. Liao W, Sun L, Wang C, Huang H, Liu J, Liao W, Shi M. LC3A-positive “stone-like” structures predict an adverse prognosis of gastric cancer. Anat Rec (Hoboken). 2014;297:653–62.
26.
Zurück zum Zitat Xi SY, Lu JB, Chen JW, et al. The “stone-like” pattern of LC3A expression and its clinicopathologic significance in hepatocellular carcinoma. Biochem Biophys Res Commun. 2013;431:760–6.PubMed Xi SY, Lu JB, Chen JW, et al. The “stone-like” pattern of LC3A expression and its clinicopathologic significance in hepatocellular carcinoma. Biochem Biophys Res Commun. 2013;431:760–6.PubMed
27.
Zurück zum Zitat Spowart JE, Townsend KN, Huwait H, et al. The autophagy protein LC3A correlates with hypoxia and is a prognostic marker of patient survival in clear cell ovarian cancer. J Pathol. 2012;228:437–47.PubMed Spowart JE, Townsend KN, Huwait H, et al. The autophagy protein LC3A correlates with hypoxia and is a prognostic marker of patient survival in clear cell ovarian cancer. J Pathol. 2012;228:437–47.PubMed
28.
Zurück zum Zitat Sivridis E, Giatromanolaki A, Zois C, et al. The “stone-like” pattern of autophagy in human epithelial tumors and tumor-like lesions. An approach to the clinical outcome. Autophagy. 2010;6:122–5. Sivridis E, Giatromanolaki A, Zois C, et al. The “stone-like” pattern of autophagy in human epithelial tumors and tumor-like lesions. An approach to the clinical outcome. Autophagy. 2010;6:122–5.
29.
Zurück zum Zitat Feng Y, He D, Yao Z, Klionsky DJ. The machinery of macroautophagy. Cell Res. 2014;24:24–41.PubMed Feng Y, He D, Yao Z, Klionsky DJ. The machinery of macroautophagy. Cell Res. 2014;24:24–41.PubMed
30.
Zurück zum Zitat Mizushima N. Autophagy: process and function. Genes Dev. 2007;21:2861–73.PubMed Mizushima N. Autophagy: process and function. Genes Dev. 2007;21:2861–73.PubMed
31.
Zurück zum Zitat Klionsky DJ, Baehrecke EH, Brumell JH, et al. A comprehensive glossary of autophagy-related molecules and processes (2nd ed.). Autophagy 2011;7:1273–94.PubMedPubMedCentral Klionsky DJ, Baehrecke EH, Brumell JH, et al. A comprehensive glossary of autophagy-related molecules and processes (2nd ed.). Autophagy 2011;7:1273–94.PubMedPubMedCentral
32.
Zurück zum Zitat Musiwaro P, Smith M, Manifava M, et al. Characteristics and requirements of basal autophagy in HEK 293 cells. Autophagy. 2013;9:1407–17.PubMed Musiwaro P, Smith M, Manifava M, et al. Characteristics and requirements of basal autophagy in HEK 293 cells. Autophagy. 2013;9:1407–17.PubMed
33.
Zurück zum Zitat Li LT, Jiang G, Chen Q, et al. Ki67 is a promising molecular target in the diagnosis of cancer (review). Mol Med Rep. 2015;11:1566–72.PubMed Li LT, Jiang G, Chen Q, et al. Ki67 is a promising molecular target in the diagnosis of cancer (review). Mol Med Rep. 2015;11:1566–72.PubMed
34.
Zurück zum Zitat Joshi S, Schjølberg AR, Ekstrøm PO, et al. Tp53/p53 status in keratoacanthomas. J Cutan Pathol. 2016;43:571–8.PubMed Joshi S, Schjølberg AR, Ekstrøm PO, et al. Tp53/p53 status in keratoacanthomas. J Cutan Pathol. 2016;43:571–8.PubMed
35.
Zurück zum Zitat Watanabe IC, Magalhães RF, de Moraes AM, et al. Keratoacanthoma and keratoacanthoma-like squamous cell carcinoma: similar morphology but different pathogenesis. Medicine (Baltimore). 2015;94:e934. Watanabe IC, Magalhães RF, de Moraes AM, et al. Keratoacanthoma and keratoacanthoma-like squamous cell carcinoma: similar morphology but different pathogenesis. Medicine (Baltimore). 2015;94:e934.
36.
Zurück zum Zitat Martinet W, Roth L, De Meyer GRY, Standard immunohistochemical assays to assess autophagy in mammalian tissue. Cells. 2017;6(3):17.PubMedCentral Martinet W, Roth L, De Meyer GRY, Standard immunohistochemical assays to assess autophagy in mammalian tissue. Cells. 2017;6(3):17.PubMedCentral
37.
Zurück zum Zitat Brantsch KD, Meisner C, Schönfisch B, et al. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. Lancet Oncol. 2008;9:713–20.PubMed Brantsch KD, Meisner C, Schönfisch B, et al. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. Lancet Oncol. 2008;9:713–20.PubMed
38.
Zurück zum Zitat Amorim E. Solitary fibrous tumor of the pleura: 3 case reports. Rev Assoc Med Bras. 2015;61:207–8.PubMed Amorim E. Solitary fibrous tumor of the pleura: 3 case reports. Rev Assoc Med Bras. 2015;61:207–8.PubMed
39.
Zurück zum Zitat Thway K, Ng W, Noujaim J, et al. The current status of solitary fibrous tumor: diagnostic features, variants, and genetics. Int J Surg Pathol. 2016;24:281–92.PubMed Thway K, Ng W, Noujaim J, et al. The current status of solitary fibrous tumor: diagnostic features, variants, and genetics. Int J Surg Pathol. 2016;24:281–92.PubMed
40.
Zurück zum Zitat Strickland KC, Nucci MR, Esselen KM, et al. Solitary fibrous tumor of the uterus presenting with lung metastases: a case report. Int J Gynecol Pathol. 2016;35:25–9.PubMed Strickland KC, Nucci MR, Esselen KM, et al. Solitary fibrous tumor of the uterus presenting with lung metastases: a case report. Int J Gynecol Pathol. 2016;35:25–9.PubMed
41.
Zurück zum Zitat Akahane K, Kato K, Ogiso S, Sakaguchi K, et al. Malignant granular cell tumor of the breast: case report and literature review. Breast Cancer. 2015;22:317–23.PubMed Akahane K, Kato K, Ogiso S, Sakaguchi K, et al. Malignant granular cell tumor of the breast: case report and literature review. Breast Cancer. 2015;22:317–23.PubMed
42.
Zurück zum Zitat Martignoni G, Pea M, Zampini C, et al. PEComas of the kidney and of the genitourinary tract. Semin Diagn Pathol. 2015;32:140–59.PubMed Martignoni G, Pea M, Zampini C, et al. PEComas of the kidney and of the genitourinary tract. Semin Diagn Pathol. 2015;32:140–59.PubMed
43.
Zurück zum Zitat Doyle LA, Hornick JL, Fletcher CD. PEComa of the gastrointestinal tract: clinicopathologic study of 35 cases with evaluation of prognostic parameters. Am J Surg Pathol. 2013;37:1769–82.PubMed Doyle LA, Hornick JL, Fletcher CD. PEComa of the gastrointestinal tract: clinicopathologic study of 35 cases with evaluation of prognostic parameters. Am J Surg Pathol. 2013;37:1769–82.PubMed
44.
Zurück zum Zitat Do BA, Varshney R, Zawawi F, et al. Inflammatory myofibroblastic tumor of the larynx-a case report. J Voice. 2014;28:258–61.PubMed Do BA, Varshney R, Zawawi F, et al. Inflammatory myofibroblastic tumor of the larynx-a case report. J Voice. 2014;28:258–61.PubMed
45.
Zurück zum Zitat Lai LM, McCarville MB, Kirby P, et al. Shedding light on inflammatory pseudotumor in children: spotlight on inflammatory myofibroblastic tumor. Pediatr Radiol. 2015;45:1738–52.PubMed Lai LM, McCarville MB, Kirby P, et al. Shedding light on inflammatory pseudotumor in children: spotlight on inflammatory myofibroblastic tumor. Pediatr Radiol. 2015;45:1738–52.PubMed
46.
Zurück zum Zitat Strieth S, Hartschuh W, Pilz L, et al. Carcinoma-like vascular density in atypic keratoacanthoma suggests malignant progression. Br J Cancer. 2002;87:1301–7.PubMedPubMedCentral Strieth S, Hartschuh W, Pilz L, et al. Carcinoma-like vascular density in atypic keratoacanthoma suggests malignant progression. Br J Cancer. 2002;87:1301–7.PubMedPubMedCentral
47.
Zurück zum Zitat Chow TK, Chacko E, Cleary C, et al. Keratoacanthoma of the lower eyelid. Eye (Lond). 2005;19:689–90. Chow TK, Chacko E, Cleary C, et al. Keratoacanthoma of the lower eyelid. Eye (Lond). 2005;19:689–90.
48.
Zurück zum Zitat Clausen OP, Aass HC, Beigi M, et al. Are keratoacanthomas variants of squamous cell carcinomas? A comparison of chromosomal aberrations by comparative genomic hybridization. J Invest Dermatol. 2006;126:2308–15.PubMedPubMedCentral Clausen OP, Aass HC, Beigi M, et al. Are keratoacanthomas variants of squamous cell carcinomas? A comparison of chromosomal aberrations by comparative genomic hybridization. J Invest Dermatol. 2006;126:2308–15.PubMedPubMedCentral
Metadaten
Titel
Patterns of LC3A Autophagy Protein Expression in Keratoacanthomas
verfasst von
Efthimios Sivridis
Ioannis M. Koukourakis
Stella Arelaki
Kostantina Balaska
Antonios Karpouzis
Alexandra Giatromanolaki
Publikationsdatum
11.04.2019
Verlag
Springer US
Erschienen in
Head and Neck Pathology / Ausgabe 1/2020
Elektronische ISSN: 1936-0568
DOI
https://doi.org/10.1007/s12105-019-01033-1

Weitere Artikel der Ausgabe 1/2020

Head and Neck Pathology 1/2020 Zur Ausgabe

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …